EXTH-23. ANTISECRETORY FACTOR-MEDIATED LOWERING OF INTERSTITIAL FLUID PRESSURE PRODUCES ANTI-TUMOR ACTIVITY IN GLIOBLASTOMA

Autor: Daniele Arosio, Aaron Frantz, William A. Weiss, Valerie M. Weaver, Shirin IIkhanizadeh, Dandan Sun, Anders Persson, Janna K. Mouw, Wen Zhu, Edith Yuan, Yekaterina A. Miroshnikova, Sergey Magnitsky, Hanna Sabelström, Mitchel S. Berger, Aurora Irene Idilli, Supna Saxena, Jason A. Burdick, David A. Quigley, Trenten Fenster
Rok vydání: 2017
Předmět:
Zdroj: Neuro-Oncology. 19:vi77-vi77
ISSN: 1523-5866
1522-8517
DOI: 10.1093/neuonc/nox168.317
Popis: Glioblastoma (GBM) is among the most aggressive cancers. Although high interstitial fluid pressure presents a barrier to drug uptake, how mechanical stresses and osmotic changes impact tumor biology remains unclear. We show that inhibition of the sodium-potassium-chloride co-transporter 1 (NKCC1) hindered proliferation and invasion of GBM cells. Compressive pressures actually promoted proliferation of GBM, an effect antagonized by the NKKC1 inhibitor bumetanide, which penetrates poorly into brain, or antisecretory factor, a protein that readily accumulates in brain, and has been used clinically. Antisecretory factor reduced IFP in patient-derived GBM xenografts. Both antisecretory factor and bumetanide inhibited osmotic adaptation of cultured GBM cells. In vivo, antisecretory factor reduced tumor growth, increased uptake of chemotherapeutics, and promoted temozolomide-sensitivity in therapy-resistant GBM xenografts. Thus, antisecretory factor represents a novel strategy to improve outcome in GBM patients.
Databáze: OpenAIRE